Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
A
Andrew Dagens
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
3.7K
Citations
21
h-index
28
i10-index
Andrew Dagens is an academic researcher. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19 & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 21, co-authored 48 publications.
ORCID: 0000-0003-4982-6690Papers by this author
worksBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review
2020 · BMJ · 165 citations
https://doi.org/10.1136/bmj.m1936
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
2022 · The Lancet Infectious Diseases · 96 citations
https://doi.org/10.1016/s1473-3099(22)00806-4
Neurological manifestations of COVID-19 in adults and children
2022 · Brain · 83 citations
https://doi.org/10.1093/brain/awac332
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat